Physician profile
Mark E Bigler
NPI 1073517066
$5,207.26
in general payments reported to CMS, 2019-2025
47 companies · $1,371 in 2025
The $1,371 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $214 · 2020: $214 · 2021: $490 · 2022: $563 · 2023: $1,041 · 2024: $1,314 · 2025: $1,371.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,327 · Education: $399.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,327.30 |
| Education | $399.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $833.03 | 2019-2025 | Xtandi, Myrbetriq |
| Janssen Biotech, INC. | $437.20 | 2020-2025 | Erleada, Balversa, Akeega |
| Abbvie INC. | $419.70 | 2019-2025 | Lupron Depot, Botox |
| Accord Healthcare, INC. | $379.57 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $346.61 | 2023-2025 | Orgovyx, Gemtesa |
| Urogen Pharma, INC. | $281.91 | 2021-2025 | Jelmyto |
| Pfizer INC. | $215.12 | 2021-2025 | |
| Endo Pharmaceuticals INC. | $156.06 | 2019-2024 | Aveed, Xiaflex |
| Boston Scientific Corporation | $153.71 | 2021-2025 | Lithovue, Spaceoar Vue System - 10ml, Rezum Generator |
| Myovant Sciences INC. | $153.03 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $132.05 | 2023-2025 | Bard Urinary Drainage Bag |
| Procept Biorobotics Corporation | $128.70 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Bayer Healthcare Pharmaceuticals INC. | $128.13 | 2022-2025 | |
| Verity Pharmaceuticals INC. | $124.54 | 2022-2024 | Trelstar |
| Endo USA, INC. | $114.56 | 2024-2025 | Xiaflex, Aveed |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Bigler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.